FDA accepts ALK’s allergy application
![Foto: Carsten Bundgaard](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article5444320.ece/ALTERNATES/schema-16_9/JensBager05%2520-%2520Kreditering%2520Carsten%2520Bundgaard.jpg)
One of the next great sources of income for Danish allergy group ALK-Abello has moved to the next level, as US partner Merck last week learned that FDA has agreed to review the registration application for ragweed AIT.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.